Using the 2 Stage Free Cash Flow to Equity, Hikma Pharmaceuticals fair value estimate is UK£37.96 Analyst price target for HIK is US$23.28 which is 39% below our fair value estimate In this ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

Hikma Pharmaceuticals (GB:HIK) has released an update. Hikma Pharmaceuticals has decided to reappoint PricewaterhouseCoopers LLP as its external auditor starting in 2026, following a competitive ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

1 Day HKMPY -1.30% DJIA 0.11% S&P 500 0.02% Health Care/Life Sciences -1.00% ...

Shares of Hikma Pharmaceuticals PLC HIK inched up 0.33% to £18.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0. ...

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Primus announced Tuesday that the funk metal band’s longtime drummer, Tim “Herb” Alexander, has abruptly left the group, saying he “lost his passion for playing.” Founding members Les ...

Tim “Herb” Alexander wants everyone to know he’s okay. Days earlier, Primus — the drummer’s now-former band — announced in a statement that Alexander had “abruptly” quit the band ...